Back

Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS)

1 September 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Advances in Treatment of Acute Coronary Syndrome Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Tian Zhao

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Low-density lipoprotein cholesterol <50 mg/dL is an appropriate target after acute coronary syndrome: propensity score-matched analysis of the ODYSSEY OUTCOMES trial
Professor G. Schwartz (Aurora, US)
Abstract Slides Video
Presentation thumbnail
Onyx ONE: Outcomes in patients with acute coronary syndrome
Doctor E. Kedhi (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Differences in revascularization strategy and outcomes in ST-elevation and non-ST-elevation myocardial infarction with spontaneous coronary artery dissection
Doctor T. Inohara (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Prasugrel compared to ticagrelor in primary PCI
Doctor J. Doerler (Klagenfurt, AT)
Abstract Slides Video
Presentation thumbnail
Sex disparities in completeness of revascularisation and outcomes in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
Doctor N. Mahdi (Calgary, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in Treatment of Acute Coronary Syndrome

The Event

Event poster

ESC Congress 2020

1 September 2020 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources